Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

D. Michelson, D. Faries, J. Wernicke, D. Kelsey, K. Kendrick, F. R. Sallee, T. Spencer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)E83
JournalPediatrics
Volume108
Issue number5
DOIs
StatePublished - Nov 2001
Externally publishedYes

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health

Cite this